Lexpos News

The Community Pharmacy IT Group (CP ITG), of which PSNC is a member, has submitted a formal response to Parliament’s Health and Social Care Committee inquiry into ‘Digital Transformation in the NHS’. The inquiry is exploring the current use of digital technology within the NHS and is examining changes that could result in improved service [...]

The post CP ITG consultation response on NHS digital transformation appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (03/08/2022) granted the following final list of price concessions: Drug Pack size Price concession Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 60 £36.13 Duloxetine 30mg gastro-resistant capsules 28 £4.28 Duloxetine 60mg gastro-resistant capsules 28 £6.91 Fluoxetine 20mg/5ml oral solution 70 £3.79 Risperidone 500microgram tablets 20 [...]

The post July Price Concessions Final Update appeared first on PSNC Website.

NHS Prescription Services produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 48) contains some useful information and advice on: Batch submissions – Account Identifier Document Licensed medicines RTEC DWP work complete NMS returns not required Q1 DDA conference – book your place Endorsing SSPs dm+d browser Electronic Repeat [...]

The post NHS Prescription Services ‘Hints & Tips’ – Issue 48 appeared first on PSNC Website.

During the month of July 2022, PSNC received several reports from contractors unable to obtain Promethazine hydrochloride 10mg tablets (56) at the published Drug Tariff price of £4.24. PSNC submitted a request for a price concession, which was granted and subsequently published but this was later withdrawn after confirmation from the Department of Health and [...]

The post Adjusted price for Promethazine hydrochloride 10mg tablets following price changes in July 2022 appeared first on PSNC Website.

Robbie Turner has been appointed as PSNC’s Chief Transformation Officer, to work closely with LPCs as part of the Transforming Pharmacy Representation (TAPR) Programme of work. PSNC launched the TAPR Programme in response to the contractor vote in favour of the Review Steering Group’s proposals. As part of the programme – alongside actioning the recommendations [...]

The post PSNC appoints Chief Transformation Officer appeared first on PSNC Website.